Inflammation markers linked to complications in type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cross-sectional analysis of adults with type 2 diabetes treated at Nanfang Hospital between January 2018 and August 2023. The study measures a range of inflammatory indicators and compares levels between patients with and without diabetes-related complications. Researchers aim to identify early predictors and to screen high-risk groups using routinely collected clinical and laboratory data. Because the design is cross-sectional, it looks for associations rather than proving cause-and-effect.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with a normative diagnosis of type 2 diabetes
* Age ≥20 years old, regardless of gender
* From January 2018 to August 2023, he was treated in Nanfang Hospital

Exclusion Criteria:

* In the acute infection phase
* The researchers judged that it was not suitable to participate in this study

Where it's running

• Department of Endocrinology and Metabolism, Nanfang Hospital, Southern Medical University
  Guangzhou, Guangdong, China Recruiting

Study contacts

• Study coordinator: Mengchen Zou Zou, Professor
• Email: zoumc163@163.com
• Phone: +86 18688423756

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing

  A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.

  Recruiting Second Affiliated Hospital of Nanchang University · Nanchang, Jang XI · NCT07881588

• DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman

  A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.

  Recruiting Oman Ministry of Health · Muscat · NCT07815275

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes

  This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.

  Recruiting Maxima Medical Center · Eindhoven, North Brabant · NCT07812623

• Linking social care with healthcare to help manage chronic diseases

  This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.

  Recruiting at 2 sites University of Arizona · Tucson, Arizona and 1 other locations · NCT07799961

• Transcutaneous and topical photobiomodulation for diabetic foot ulcers

  This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.

  Recruiting Phase 2 University of Nove de Julho · Teresina, Piauí · NCT07798960

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.